For instance, FXYD2 is differentially expressed in cholangiocarcinoma cells, as is FXYD5 in epithelioid sarcoma, head and neck squamous cell carcinoma, small cell carcinoma, pancreatic cancer cells and breast cancer cells. This evidence concerns the gene FXYD2 and cholangiocarcinoma.